Aandelen in “Medicinale en botanische productie”

Aandeel Datum Koers Evolutie
vlag Natural Alternatives International, Inc. 21/08 2,150 USD
+3,86% 		+3,86%
vlag NervGen Pharma Corp 21/08 1,860 USD
+5,68% 		+5,68%
vlag Novartis AG 21/08 158,860 USD
+1,68% 		+1,68%
vlag Novartis AG 21/08 127,420 CHF
+0,85% 		+0,85%
vlag Novo Nordisk A/S 21/08 46,740 USD
+1,30% 		+1,30%
vlag Novo Nordisk A/S 21/08 40,150 EUR
+0,98% 		+0,98%
vlag Nuformix plc 21/08 0,165 GBX
-2,94% 		-2,94%

Nieuws over “Medicinale en botanische productie”

21/08 · Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline · Persbericht

21/08 · Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline · Persbericht

20/08 · Ipsen - July 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital · Persbericht

20/08 · Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand · Persbericht

19/08 · Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market · Persbericht

19/08 · AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC. · Persbericht

19/08 · Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies · Persbericht

18/08 · BrewDog Unwraps Its 2026 Advent Calendar · Persbericht

18/08 · Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development · Persbericht

18/08 · Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders? · Persbericht

17/08 · IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2026 · Persbericht

17/08 · Novo Nordisk A/S - share repurchase programme · Persbericht

17/08 · USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix · Persbericht

17/08 · Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary · Persbericht

17/08 · AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026 · Persbericht

16/08 · Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award · Persbericht

14/08 · Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update · Persbericht

14/08 · Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update · Persbericht

14/08 · Brusselse beurs: fanmail voor Syensqo animeert kabbelende zomerdag · Tijd.be (€)

opese beurzen blijven dicht bij huis. Op de Brusselse beurs kennen UCB en Argenx een klein zomerdipje. De chemiegroep Syensqo krijgt fanmail uit New York.

12/08 · Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri · Persbericht

12/08 · High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders · Persbericht

Mijn selecties